---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-030023"
form_type: "8-K"
ticker: "SFES"
cik: "0000086115"
company_name: "SAFEGUARD SCIENTIFICS INC"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T01:24:13.601717+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Safeguard Scientifics Q3 net income $0.9M, vs loss $3.2M; cash $15.7M

## Summary
- Q3 net income $0.9M ($0.06 diluted EPS) vs net loss $3.2M ($0.19 loss) in Q3 2022.
- 9M net loss narrowed to $5.4M ($0.33 loss) from $9.4M ($0.57 loss) year earlier.
- Cash and equivalents $15.7M; carrying value of ownership interests $14.8M (cost $122.8M).
- InfoBionic recap reduced ownership to ~5% with $1.7M non-cash gain; Trice Medical recap resulted in de minimis stake.
- Aggregate trailing 12-month revenue of six portfolio companies $96M, up 10.3% YoY.

## SEC filing metadata
- accession: 0001437749-23-030023
- form_type: 8-K
- ticker: SFES
- cik: 0000086115
- company_name: SAFEGUARD SCIENTIFICS INC
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/86115/000143774923030023/0001437749-23-030023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/86115/000143774923030023/sfe20231102_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-030023
- JSON: https://secwatch.observer/filing/0001437749-23-030023.json
- Plain text: https://secwatch.observer/filing/0001437749-23-030023.txt

## Key facts
- Earnings Releases
  SAFEGUARD SCIENTIFICS INC reported the three and nine months ended September 30, 2023 results: net income Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, a.
  - Period: the three and nine months ended September 30, 2023
  - Net income: Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, a
  - Result: reported results
  source text: o Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, as compared with a net loss of $3.2 million, or $0.19 per basic and fully diluted share, for the same period in 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/86115/000143774923030023/0001437749-23-030023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.